Fibrobiologics, Inc.: FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.
FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.
Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure
Acute heart failure, or AHF, impacts millions of patients around the world and its cost to healthcare systems is significant,” said Jed Latkin, CEO of Windtree. “We believe that drug innovation is ...
Windtree Therapeutics announces notice of allowance from USPTO for istaroxime
Windtree Therapeutics (WINT) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. application ...
TMCnet57m
FICO Announces 12 New Patents, Advancing Responsible AI, Machine Learning, and Applied Intelligence Technology
Global analytics software leader FICO was awarded new patents by the U.S. Patent and Trademark Office, encompassing technologies in fraud, artificial intelligence, machine learning, decision ...